Kristina Iribarren

Medicine · Health Sciences

20h-index7.5kcitations35works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(14), Immune Response and Inflammation(9), Immune cells in cancer(9), Lung Cancer Treatments and Mutations(7), Lung Cancer Diagnosis and Treatment(5)

Publications35 total

Data from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Data Supplement from TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer
2023Open Access
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
Cell Death and Differentiation·2021· 46 citedOpen Access
Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
Aging·2021· 148 citedOpen Access
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications·2020· 1 citedOpen Access
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications·2020· 129 citedOpen Access
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
European Urology·2020· 350 citedOpen Access
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
OncoImmunology·2019· 72 citedOpen Access
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Journal of Vascular and Interventional Radiology·2019· 17 cited
Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Nature Communications·2019· 13 citedOpen Access
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Nature Communications·2019· 285 citedOpen Access
Anticancer effects of anti-CD47 immunotherapy <i>in vivo</i>
OncoImmunology·2018· 40 citedOpen Access
Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals
Cell Death and Disease·2018· 23 citedOpen Access
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
OncoImmunology·2018· 45 citedOpen Access
Abstract 5752: Protumoral and pro-metastatic effects of TLR7 in lung cancer
Cancer Research·2018
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice
Frontiers in Immunology·2018· 19 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Guido Kroemer(22), Laurence Zitvogel(18), Isabelle Cremer(16), Oliver Kepp(13), Diane Damotte(10), Marco Alifano(10), Peng Liu(9), Liwei Zhao(9), Wolf H. Fridman(9), Takahiro Yamazaki(8), Lucillia Bezu(8), Sylvère Durand(8), Jérémy Goc(8), Marie‐Caroline Dieu‐Nosjean(8), Catherine Sautès‐Fridman(8), Laura Mondragón(7), Saradiya Chatterjee(7), Lucile Crozet(7), Catherine Schramm(7), Julien Cherfils‐Vicini(7)